ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation
Conditions
Interventions
- DRUG: administration of SLGN in arm C
- DRUG: Discontinuation of NUC treatment in arms B and C
Sponsor
ANRS, Emerging Infectious Diseases
Collaborators